Charles River Laboratories | Zahlungsmittel Und Äquivalente



Cash And Equivalent Veränderung Datum
Agilent USD 1.47B 138M 2025-01
Align Technology USD 1.04B 1.95M 2024-12
Bio-Rad Laboratories USD 488.1M 77.72M 2024-12
Bruker USD 183.4M 35.3M 2024-12
Cardinal Health USD 3.81B 943M 2024-12
Charles River Laboratories USD 194.61M 15.56M 2024-12
Cigna USD 7.55B 1.66B 2024-12
CVS Health USD 8.59B 1.71B 2024-12
Danaher USD 2.08B 549M 2024-12
Dentsply International USD 272M 24M 2024-12
Elevance Health USD 8.29B 422M 2024-12
Galapagos EUR 64.24M 8.72M 2024-12
Hologic USD 1.78B 378.1M 2024-12
Humana USD 2.22B 2.9B 2024-12
Illumina USD 1.13B 258M 2024-12
Incyte USD 1.69B 383.72M 2024-12
IQVIA Holdings USD 1.7B 130M 2024-12
Laboratory Of America USD 1.52B 1.4M 2024-12
Lonza CHF 1.11B 286M 2024-12
McKesson USD 1.13B 1.38B 2024-12
Merck EUR 2.15B 1.01B 2024-12
Mettler Toledo International USD 59.36M 12.21M 2024-12
Novartis USD 8.87B 4.74B 2024-12
Pfizer USD 1.04B 49M 2024-12
Quest Diagnostics USD 549M 215M 2024-12
Revvity USD 1.16B 66.38M 2024-12
Thermo Fisher Scientific USD 4.01B 636M 2024-12
United Therapeutics USD 1.7B 143.3M 2024-12
UnitedHealth USD 25.31B 7.09B 2024-12
Walgreens Boots Alliance USD 702M 157M 2025-02
Waters USD 324.42M 6.09M 2024-12
West Pharmaceutical Services USD 484.6M 6.3M 2024-12



Charles River Laboratories Zahlungsmittel Und Äquivalente - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2025.